Top Markets
#1 Seeker Seeker +129.13%
#2 MowCat MowCat +107.71%
#3 AI XOVIA AI XOVIA +105.43%
#4 Helium Helium +86.38%
#5 Pons Pons +55.10%
#6 UnifAI Network UnifAI Network +34.96%
#7 Zora Zora +31.04%
#8 Bounce Bounce +21.20%
#9 Zylo Ecosystem Zylo Ecosystem +21.16%
#10 Tensor Tensor +18.98%
Coin of the day
Seeker Seeker
설정
언어
한국어
통화
USD
테마
Jacobio Pharmaceuticals Group Co., Ltd. Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd.

1167
주식 순위 #11796
Jacobio Pharmaceuticals Group Co., Ltd. is a clinical-stage pharmaceutical firm... Jacobio Pharmaceuticals Group Co., Ltd. is a clinical-stage pharmaceutical firm specializing in the proprietary discovery and development of oncology therapies. Its primary drug development initiatives feature two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors, JAB-3312 and JAB-3068, which are being investigated for esophageal cancer. Also in development is JAB-8263, a small molecule designed to inhibit BET family proteins that regulate MYC transcription, aiming to treat a range of cancers, alongside JAB-21822, an oral small molecule specifically targeting the mutant KRAS G12C protein. Jacobio is further advancing JAB-BX102, a humanized inhibitory antibody against human CD73, intended for treating PD-1 resistant cancers. Other pipeline assets include JAB-6343, an inhibitor targeting fibroblast growth factor receptor 4 for advanced hepatocellular carcinoma exhibiting FGF19 overexpression; JAB-2485, an aurora A kinase inhibitor for solid tumors; JAB-24114, which targets a tumor metabolic pathway for solid tumor treatment; and JAB-BX300, a molecular antibody designed to target the RAS pathway for pancreatic and other solid tumors with KRAS mutations. The company maintains a strategic partnership with AbbVie Ireland Unlimited Company for the development and commercialization of SHP2 inhibitors. Established in 2015, Jacobio Pharmaceuticals is headquartered in Beijing, China.
주가
$0.84111496
마지막 동기화: 2026-08-28
시가총액
$657.90M
변동 (1일)
-0.75%
변동 (1년)
-19.13%
국가
CN
거래 Jacobio Pharmaceuticals Group Co., Ltd. (1167)

카테고리

Healthcare
Jacobio Pharmaceuticals Group Co., Ltd. (1167)의 주가 이력
최고 종가: $0.70 (2026-08-01 기준)

최저 종가: $1.84 (2020-12-01 기준)
Jacobio Pharmaceuticals Group Co., Ltd.의 주가 이력 (2020 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -15.43%
2025 484.68%
2024 -61.65%
2023 -33.34%
2022 -61.78%
2021 -1.98%
2020 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH